Baxter International Inc. provides a broad portfolio of essential renal and hospital products, including home, acute and in-centre dialysis; sterile IV solutions; infusion systems and devices; parenteral nutrition; biosurgery products and anaesthetics; and pharmacy automation, software and services. The company’s global footprint and the critical nature of its products and services play a key role in expanding access to healthcare in emerging and developed countries. Baxter’s 50,000 employees worldwide are building upon the company’s rich heritage of medical breakthroughs to advance the next generation of healthcare innovations that enable patient care.
In 1972, construction began on a new manufacturing facility at Castlebar, Co. Mayo, with a second facility at Swinford only five years later. Today these two facilities occupy 300,000 square feet and directly employ over 1,000 people with as many more benefiting indirectly. The company also has two sales and marketing bases in Ireland (Dublin and Belfast) and a Financial Shared-Services operation in Dublin.
The Castlebar plant concentrates on the manufacture of renal dialysis solutions, pre-mixed intravenous solutions and a range of drug products while the plant at Swinford specializes in the manufacture of componentry for administration of the solutions to patient’s. The markets served from Mayo include the U.K. and all of mainland Europe, the U.S., Japan and the more developed markets in Asia.
Please enter your email address